Regulators of vascular permeability: potential sites for intervention in the treatment of macular edema
- PMID: 10896338
- DOI: 10.1023/a:1002196930726
Regulators of vascular permeability: potential sites for intervention in the treatment of macular edema
Abstract
Rather than being a non-specific reaction to a noxious stimulus, breakdown of the capillary blood-retinal barrier causing macular edema appears to be dependent on a number of active processes which may be open to pharmacological manipulation. Extracellular influences which may affect barrier function include serum and neighboring cell types, which act though cytokines, such as vascular endothelial growth factor and transforming growth factor-beta, and other factors. A number of intracellular pathways acting on the cytoskeleton and components of the intercellular junctional complexes have been identified which mediate agonist-induced leak of the vascular endothelium. The further elucidation of these processes may be useful in the development of better treatments for breakdown of the inner blood-retinal barrier.
Similar articles
-
Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.Acta Ophthalmol. 2019 Mar;97(2):214-224. doi: 10.1111/aos.13909. Epub 2018 Aug 31. Acta Ophthalmol. 2019. PMID: 30168271
-
The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.Fluids Barriers CNS. 2018 Sep 20;15(1):24. doi: 10.1186/s12987-018-0109-2. Fluids Barriers CNS. 2018. PMID: 30231925 Free PMC article. Review.
-
BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1821-1836. doi: 10.1161/ATVBAHA.118.310733. Arterioscler Thromb Vasc Biol. 2018. PMID: 29880487
-
The pathogenesis of edema in diabetic maculopathy.Semin Ophthalmol. 1999 Dec;14(4):223-32. doi: 10.3109/08820539909069541. Semin Ophthalmol. 1999. PMID: 10758223 Review.
-
Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.Am J Pathol. 2016 Apr;186(4):1044-54. doi: 10.1016/j.ajpath.2015.11.019. Epub 2016 Feb 12. Am J Pathol. 2016. PMID: 26878208
Cited by
-
Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy.Diabetes. 2012 Nov;61(11):2948-57. doi: 10.2337/db11-0300. Epub 2012 Aug 13. Diabetes. 2012. PMID: 22891217 Free PMC article.
-
[Cystoid macular edema in uveitis].Ophthalmologe. 2005 May;102(5):485-90. doi: 10.1007/s00347-005-1183-9. Ophthalmologe. 2005. PMID: 15747121 German.
-
Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase.J Biol Chem. 2009 Oct 30;284(44):30177-86. doi: 10.1074/jbc.M109.032391. Epub 2009 Sep 1. J Biol Chem. 2009. PMID: 19723623 Free PMC article.
-
Radiation Retinopathy: Detection and Management Strategies.Clin Ophthalmol. 2021 Sep 8;15:3797-3809. doi: 10.2147/OPTH.S219268. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34526764 Free PMC article. Review.
-
Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.Br J Ophthalmol. 2017 Dec;101(12):1694-1698. doi: 10.1136/bjophthalmol-2017-310315. Epub 2017 Apr 17. Br J Ophthalmol. 2017. PMID: 28416492 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources